期刊
PEDIATRIC DIABETES
卷 18, 期 4, 页码 320-323出版社
WILEY
DOI: 10.1111/pedi.12512
关键词
CACNA1D; calcium channel; exome sequencing; hyperinsulinism; hypoglycaemia
资金
- Medical Research Council [98144]
- Wellcome Trust
- Royal Society [105636/Z/14/Z]
Congenital hyperinsulinaemic hypoglycaemia (HH) can occur in isolation or it may present as part of a wider syndrome. For approximately 40%-50% of individuals with this condition, sequence analysis of the known HH genes identifies a causative mutation. Identifying the underlying genetic aetiology in the remaining cases is important as a genetic diagnosis will inform on recurrence risk, may guide medical management and will provide valuable insights into beta-cell physiology. We sequenced the exome of a child with persistent diazoxide-responsive HH, mild aortic insufficiency, severe hypotonia, and developmental delay as well as the unaffected parents. This analysis identified a de novo mutation, p.G403D, in the proband's CAC-NA1D gene. CACNA1D encodes the main L-type voltage-gated calcium channel in the pancreatic beta-cell, a key component of the insulin secretion pathway. The p. G403D mutation had been reported previously as an activating mutation in an individual with primary hyperaldosteronism, neuromuscular abnormalities, and transient hypoglycaemia. Sequence analysis of the CACNA1D gene in 60 further cases with HH did not identify a pathogenic mutation. Identification of an activating CACNA1D mutation in a second patient with congenital HH confirms the aetiological role of CACNA1D mutations in this disorder. A genetic diagnosis is important as treatment with a calcium channel blocker may be an option for the medical management of this patient.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据